Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Sadeghnejad, Alireza ^a   Ohar, Jill A ^a   Zheng, Siqun L ^a   Sterling, David A ^b   Hawkins, Gregory A ^a   Meyers, Deborah A ^a   Bleecker, Eugene R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM33 PROTEIN; GLYCINE; ISOLEUCINE; PROTEIN; UNCLASSIFIED DRUG; VALINE; ADAM PROTEIN; ADAM33 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; RESIDUAL VOLUME; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CASE CONTROL STUDY; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; VITAL CAPACITY;

ADAM PROTEINS; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS; VITAL CAPACITY;

EID: 65649140139     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-21     Document Type: Article

References (28)

1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. British medical journal 1977, 1(6077):1645-1648. 1607732, 871704.
2. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. Jama 1994, 272(19):1497-1505. 10.1001/jama.272.19.1497, 7966841.
3. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006, 61(11):935-939. 10.1136/thx.2006.062802, 17071833.
4. Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, Ohar JA. IL13 Promoter Polymorphism -1112C/T Modulates the Adverse Effect of Tobacco Smoking on Lung Function. American journal of respiratory and critical care medicine 2007,
5. Bleecker ER. Similarities and differences in asthma and COPD. The Dutch hypothesis. Chest 2004, 126(2 Suppl):93S-95S. discussion 159S-161S, 10.1378/chest.126.2_suppl_1.93S, 15302768.
6. Meyers DA, Larj MJ, Lange L. Genetics of asthma and COPD. Similar results for different phenotypes. Chest 2004, 126(2 Suppl):105S-110S. discussion 159S-161S, 10.1378/chest.126.2_suppl_1.105S, 15302770.
7. Postma DS, Boezen HM. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004, 126(2 Suppl):96S-104S. discussion 159S-161S, 10.1378/chest.126.2_suppl_1.96S, 15302769.
8. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418(6896):426-430. 10.1038/nature00878, 12110844.
9. Howard TD, Postma DS, Jongepier H, Moore WC, Koppelman GH, Zheng SL, Xu J, Bleecker ER, Meyers DA. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. The Journal of allergy and clinical immunology 2003, 112(4):717-722.
10. Blakey J, Halapi E, Bjornsdottir US, Wheatley A, Kristinsson S, Upmanyu R, Stefansson K, Hakonarson H, Hall IP. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax 2005, 60(4):274-276. 1747383, 15790980, 10.1136/thx.2004.027227.
11. Holloway JW, Keith TP, Davies DE, Powell R, Haitchi HM, Holgate ST. The discovery and role of ADAM33, a new candidate gene for asthma. Expert reviews in molecular medicine [electronic resource] 2004, 6(17):1-12.
12. Werner M, Herbon N, Gohlke H, Altmuller J, Knapp M, Heinrich J, Wjst M. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy 2004, 34(1):26-31. 10.1111/j.1365-2222.2004.01846.x, 14720258.
13. Lee JH, Park HS, Park SW, Jang AS, Uh ST, Rhim T, Park CS, Hong SJ, Holgate ST, Holloway JW, et al. ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy 2004, 34(6):860-865. 10.1111/j.1365-2222.2004.01977.x, 15196271.
14. Lind DL, Choudhry S, Ung N, Ziv E, Avila PC, Salari K, Ha C, Lovins EG, Coyle NE, Nazario S, et al. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. American journal of respiratory and critical care medicine 2003, 168(11):1312-1316.
15. Jongepier H, Boezen HM, Dijkstra A, Howard TD, Vonk JM, Koppelman GH, Zheng SL, Meyers DA, Bleecker ER, Postma DS. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004, 34(5):757-760. 10.1111/j.1365-2222.2004.1938.x, 15144468.
16. Simpson A, Maniatis N, Jury F, Cakebread JA, Lowe LA, Holgate ST, Woodcock A, Ollier WE, Collins A, Custovic A, et al. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. American journal of respiratory and critical care medicine 2005, 172(1):55-60.
17. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. American journal of respiratory and critical care medicine 2005, 172(3):329-333.
18. Ohar J, Sterling DA, Bleecker E, Donohue J. Changing patterns in asbestos-induced lung disease. Chest 2004, 125(2):744-753. 10.1378/chest.125.2.744, 14769760.
19. Labour OI. ILO international classification of radiographs of pneumoconiosis: occupational safety and health series, No. 22 revised. Geneva, Switzerland 1980,
20. Standardization of Spirometry, 1994 Update American Thoracic Society. American journal of respiratory and critical care medicine 1995, 152(3):1107-1136. Standardization of Spirometry, 1994 Update.
21. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. American journal of respiratory and critical care medicine 1995, 152(5 Pt 2):S77-121.
22. Lewontin RC. The Interaction of Selection and Linkage. Ii. Optimum Models. Genetics 1964, 50:757-782. 1210693, 14221879.
23. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. American journal of human genetics 2002, 70(2):425-434. 384917, 11791212, 10.1086/338688.
24. Schedel M, Depner M, Schoen C, Weiland SK, Vogelberg C, Niggemann B, Lau S, Illig T, Klopp N, Wahn U, et al. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respiratory research 2006, 7:91. 1550399, 16784537, 10.1186/1465-9921-7-91.
25. Noguchi E, Ohtsuki Y, Tokunaga K, Yamaoka-Sageshima M, Ichikawa K, Aoki T, Shibasaki M, Arinami T. ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population. Clin Exp Allergy 2006, 36(5):602-608. 10.1111/j.1365-2222.2006.02471.x, 16650044.
26. Kedda MA, Duffy DL, Bradley B, O'Hehir RE, Thompson PJ. ADAM33 haplotypes are associated with asthma in a large Australian population. Eur J Hum Genet 2006, 14(9):1027-1036. 10.1038/sj.ejhg.5201662, 16773130.
27. Raby BA, Silverman EK, Kwiatkowski DJ, Lange C, Lazarus R, Weiss ST. ADAM33 polymorphisms and phenotype associations in childhood asthma. The Journal of allergy and clinical immunology 2004, 113(6):1071-1078.
28. Foley SC, Mogas AK, Olivenstein R, Fiset PO, Chakir J, Bourbeau J, Ernst P, Lemiere C, Martin JG, Hamid Q. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. The Journal of allergy and clinical immunology 2007, 119(4):863-871.